LimeLight of The week is
 

RYAH Group Inc.
(CSE: RYAH)

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Investment Considerations

• RYAH Group is a technological leader in the plant-based treatment market with its unique combination of proprietary IoT devices and data analytics, supported by patented AI technology.
• The company’s products pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services.
• RYAH offers a complete remote dosage delivery and dose-monitoring platform based on data-driven analytics supported by prescribing doctors and their patients.
• The company is finalizing its anticipated listing on the Canadian Securities Exchange.
• RYAH holds a unique position on the $100.3 billion medical plant market, with the potential to capture footholds in both the IoT and Data Intelligence industries.

Recent Coverage

InvestorNewsBreaks - RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

February 10, 2022 8:30 AM

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company's IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product team members, with particular thanks to our Product Operations Head, Jordan Medley, and our patent legal team. The application for this invention was initially filed on March 16, 2018, and was subject to several amendments along the way,” said Gregory Wagner, CEO of RYAH Group Inc. “We look forward to strengthening competitive positioning on our intellectual property and medical device portfolio with a number of patents pending maturing on our additional IoT products.”

To view the full article, visit: THIS LINK

Receive SMS Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

(US Mobile Phones Only)

Featured Event

Alternative Products Expo, Fort Lauderdale
March 11-13, 2022 - Ft. Lauderdale, FL

Venue: BROWARD COUNTY CONVENTION CENTER

With the allure of the city – gorgeous beaches and favorable weather – beckoning, Fort Lauderdale will host the United States’ largest CBD and hemp event: the Alternative Products Expo, from March 11 to March 13, 2022. The event will include workshops, keynotes, and educational seminars featuring more than 50 industry professionals as speakers. It will also offer networking opportunities to the thousands of expected attendees. Moreover, vendors will showcase/sell their products in their respective booths.

The Alternative Products Expo comes to Florida at a time when the state has relaxed, to some extent, its once stringent cannabis legislation. Presently, medical marijuana use is legal and more than 500,000 Floridians have active medical marijuana cards. The three-day event will focus on the business side of the cannabidiol (“CBD”) and the hemp industry, CBD’s health benefits, medicinal use, legality and current and future trends in the CBD market.

Conference Highlights

• 50+ speakers will address the thousands of expected attendees
• The event will feature vendor booths as well as workshops, keynotes and educational seminars
• Fort Lauderdale has gorgeous beaches and beautiful weather, factors that led to its selection as a host city for the Alternative Products Expo

Upcoming Events

• The Cannabis Investing Virtual Expo — Virtual Event — 3/18/22 - 3/20/22
• NECANN’s Boston Convention — Boston — 3/18/22 - 3/20/22
• BizCann Expo — Medellin, Colombia — 5/21 - 5/22

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.